AAP 2022 Bilirubin
AAP 2022 hyperbilirubinemia management guideline with phototherapy, escalation, and exchange transfusion thresholds
Clinically Verified· 10 testsFor educational and informational purposes only. Verify all results before clinical application.
hours
mg/dL
Neurotoxicity risk factors: isoimmune hemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, albumin <3.0 g/dL, or gestational age 35-37 weeks.
References
- Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.[DOI]
Reviewed by Daniel Diaz-Gil, MD · Last updated March 2026
Medical disclaimer
This tool is for educational and informational purposes only. It is not a substitute for professional clinical judgment. Always independently verify results before making clinical decisions.